Results for tag: "Zepatier"

Zepatier is a brand of antiviral drugs used to treat chronic hepatitis C virus (HCV) infection. It is a combination of two drugs, elbasvir and grazoprevir, which work together to block the virus from replicating and reduce the amount of virus in the body. Zepatier is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with HCV genotypes 1, 4, 5, and 6. It is also approved for use in combination with ribavirin for genotypes 1 and 4. The Infectious Diseases Drugs market is a rapidly growing sector of the pharmaceutical industry. It includes a wide range of drugs used to treat a variety of infectious diseases, including HIV, malaria, tuberculosis, and hepatitis C. The market is driven by the increasing prevalence of infectious diseases, the development of new drugs, and the increasing demand for more effective treatments. Some of the major companies in the Infectious Diseases Drugs market include Gilead Sciences, Merck & Co., Johnson & Johnson, Pfizer, and Bristol-Myers Squibb. Show Less Read more